Geode Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $56K | Hold |
|
|||||
|
2022
Q2 | $192K | Hold |
|
|||||
|
2022
Q1 | $423K | Buy |
|
|||||
|
2021
Q4 | $731K | Sell |
|
|||||
|
2021
Q3 | $872K | Buy |
|
|||||
|
2021
Q2 | $728K | Sell |
|
|||||
|
2021
Q1 | $835K | Buy |
|
|||||
|
2020
Q4 | $779K | Sell |
|
|||||
|
2020
Q3 | $829K | Buy |
|
|||||
|
2020
Q2 | $1.04M | Buy |
|
|||||
|
2020
Q1 | $710K | Buy |
|
|||||
|
2019
Q4 | $1.16M | Buy |
|
|||||
|
2019
Q3 | $760K | Buy |
|
|||||
|
2019
Q2 | $2.39M | Buy |
|
|||||
|
2019
Q1 | $725K | Buy |
|